Source link : https://newshealth.biz/health-news/hydroxychloroquine-slows-progression-of-cutaneous-lupus-to-sle/
TOPLINE: Early initiation of hydroxychloroquine (HCQ) in patients with cutaneous lupus erythematosus (CLE) reduces the risk for progression to systemic lupus erythematosus (SLE) by 87% over time. METHODOLOGY: Researchers conducted a longitudinal cohort study of 286 consecutive patients with isolated CLE at an autoimmune skin disease referral clinic in Israel between September 2020 and January […]
Author : News Health
Publish date : 2025-02-28 09:38:38
Copyright for syndicated content belongs to the linked Source.